Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Alliance Data Systems spinoff of Loyalty Ventures
We advised Alliance Data Systems on its spinoff transaction
Government of Belize debt restructuring
Belize completed settlement of its cash tender offer and consent solicitation for its U.S. dollar bonds due 2034
Integral Acquisition Corporation 1 $115 million IPO
The issuer, a SPAC, offered 11,500,000 units which were listed on Nasdaq
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
Fifth Third Bancorp $500 million inaugural sustainable notes offering
The company offered fixed-rate/floating-rate senior notes due 2027
Project Energy Reimagined Acquisition $250 million IPO
The issuer, a SPAC, offered 25,000,000 units which were listed on Nasdaq
SDCL EDGE Acquisition $175 million IPO
The issuer, a SPAC, offered 17,500,000 units which were listed on the NYSE
Banco Santander (Brasil) spinoff and Nasdaq listing of Getnet
We advised Santander Brasil on the transaction, including the Nasdaq listing of Getnet ADSs
Compass Digital Acquisition $200 million IPO
We advised the SPAC on its IPO and Nasdaq listing
Morgan Stanley €1.75 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering